Highlighted Sessions
Wednesday, May 1, 1:30pm–2:15pm
Brandon Allgood, chief technology officer and cofounder of Numerate, gives his perspective on artificial intelligence, the future of machine learning, and why the drug industry needs to take notice.
/ Read more /
Wednesday, May 1, 9:45am–10:30am
Time to market can be compromised by an inability to efficiently upscale or transfer an upstream process, leading to wasted time during clinical development. This presentation will focus on a new approach to this issue based on data mining, allowing an efficient and time-consistent process tech transfer and providing an advantage to drug makers for risk and yield management.
/ Read more /
Wednesday, May 1, 10:30am–11:15am
This presentation will discuss fundamental formulation and processing considerations for obtaining a high-performing and physically- and chemically-stable amorphous formulation without formulation and process iteration.
/ Read more /
Wednesday, May 1, 11:00am–11:25am
When facing the increasing complexities of small-molecule drug development, the best weapons are experience and expertise—not only in route design and organic synthesis, but also in all phases of drug development.
/ Read more /
Wednesday, May 1, 3:00pm–3:45pm
This presentation reviews how a purpose-built laboratory information management system designed for pharmaceutical-specific workflows and compliance works to ensure the integrity of data in labs that support pharmaceutical manufacturing.
/ Read more /
NEWS FROM CPhI NORTH AMERICA EXHIBITORS
Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility.
/ Read more /
Empty pharmaceutical capsules provider ACG aims to merge science and art with its new art competition worth $5000.
/ Read more /
The new service offers a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of gene and cell therapies.
/ Read more /
The acquisition of CiVentiChem’s facility in the United States is expected to enhance UK-based Sterling Pharma Solutions’ chemistry development capabilities.
/ Read more /
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
/ Read more /
CPhI NORTH AMERICA 2019 EXHIBITOR PREVIEW
|
Coating Place develops and manufactures modified release oral products.
/ read more /
|
|
CordenPharma is your full-service contract development and manufacturing (CDMO) partner for APIs, Drug Products, and Packaging services.
/ read more /
|
|
Emergent provides contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid and lyophilized products.
/ read more /
|
|
Our innovative excipients and coatings, along with our formulation expertise and biopharma services, provide our customers with a complete portfolio of solutions for the development and manufacture of solid and liquid dosage forms.
/ read more /
|
|
Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need.
/ read more /
|
Supplements
 |
Check out this month’s special issue, Solid Dosage Drug Development and Manufacturing, for articles on tableting, controlled release, powder handling, and more! The issue also includes our CPhI North America 2019 Planning Guide.
View Online
|
|
|
|
|
